StockpollyBeta
Get App
Delisting riskPopularity #4,455
KALA · NASDAQ · Biotechnology

KALA BIO (KALA)

Evaluates biotech AI infrastructure while preserving biologics assets for potential partners.

$0.5800
After hours−0.02 (−3.17%)
At close$0.5990(+6.96%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue000000000000
Gross profit000000000000
1091210109111171022
Research & development656555666000
5554445551022
General & administrative0000005551022
Other expenses00000000−3000
Operating income−11−9−12−10−10−9−11−11−7−10−2−2
2100112001100
Interest income111110000000
Interest expense111111111000
Other non-operating income0−2−1−2−2−3−3−1−1−1100
Income before tax−9−9−12−10−9−8−9−11−81−2−2
Net income from continuing operations−9−9−12−10−9−8−9−11−81−2−2
Net income−9−9−12−10−9−8−9−11−81−2−2
EPS, basic−$3.41−$3.18−$4.20−$3.16−$1.93−$1.74−$70.49−$85.50−$53.50$0.00−$7.00−$21.32
EPS, diluted−$3.41−$3.18−$4.20−$3.16−$1.93−$1.74−$70.49−$85.50−$53.50$0.00−$7.00−$21.32
Weighted average shares, basic333355000000
Weighted average shares, diluted333355000000
EBITDA−10−7−10−8−7−7−8−10−61−2−2
Depreciation & amortization000000000000
EBIT−11−7−10−8−7−7−8−10−71−2−2